John Joseph Johnston - Dec 6, 2024 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian Leaf, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Dec 6, 2024
Transactions value $
-$3,987
Form type
4
Date filed
12/10/2024, 04:30 PM
Previous filing
Oct 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $1.48K +505 +0.36% $2.93 142K Dec 6, 2024 Direct F1
transaction MXCT Common Stock Sale -$1.87K -505 -0.35% $3.70 142K Dec 6, 2024 Direct F1, F2
transaction MXCT Common Stock Options Exercise $2.61K +891 +0.63% $2.93 143K Dec 9, 2024 Direct F1
transaction MXCT Common Stock Options Exercise $1.84K +1.12K +0.78% $1.64 144K Dec 9, 2024 Direct F1
transaction MXCT Common Stock Options Exercise $1.42K +483 +0.34% $2.93 144K Dec 9, 2024 Direct F1
transaction MXCT Common Stock Sale -$9.46K -2.5K -1.73% $3.79 142K Dec 9, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Options Exercise $0 -505 -36.17% $0.00 891 Dec 6, 2024 Common Stock 505 $2.93 Direct F1, F4
transaction MXCT Stock Option (right to buy) Options Exercise $0 -891 -100% $0.00 0 Dec 9, 2024 Common Stock 891 $2.93 Direct F1, F4
transaction MXCT Stock Option (right to buy) Options Exercise $0 -1.12K -100% $0.00 0 Dec 9, 2024 Common Stock 1.12K $1.64 Direct F1, F4
transaction MXCT Stock Option (right to buy) Options Exercise $0 -483 -2.02% $0.00 23.4K Dec 9, 2024 Common Stock 483 $2.93 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.705 to $3.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option is fully vested and exercisable.